• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ASAHI KASEI MEDICAL CO., LTD. PLASMAFLO OP; PLASMA SEPARATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ASAHI KASEI MEDICAL CO., LTD. PLASMAFLO OP; PLASMA SEPARATOR Back to Search Results
Model Number OP-05W
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Pneumonia (2011)
Event Date 02/28/2018
Event Type  Injury  
Manufacturer Narrative
This incident of eosinophilic pneumonia occurred in (b)(6), and we are reporting this event to fda according to the requirement.Plasmaflo op-05w is similar model of plasmaflo op-05w(a) marketed in us.The actual used product was not returned to us for investigation and could not be analyzed, and the lot number was unknown.We have not received any event of eosinophilic pneumonia other than this case since we started selling plasmaflo op globally.Patient's physician considers that this case is serious event and that causal relationship between plasmaflo op and this event is possible, and the doctor whose hospital this patient was transferred to commented that this case is possibly related to iapp.We also consider the severity of eosinophilic pneumonia is serious injury as patient has hospitalized for the treatment of pneumonia and was given the treatment of mechanical ventilator, and the causal relationship between this device and the event could not be denied because the event happened just after iapp treatment.The caution for this event is not described in instruction for use, however this case is the first event happened on plasmaflo op, we will continue to vigilance trend in occurring this kind of event(eosinophilic pneumonia) with plasmaflo op.
 
Event Description
A (b)(6) woman started the treatment with immunoadsorption plasmapheresis(iapp) of plasmaflo op-o5w and immusorba tr-350 for myasthenia gravis on (b)(6), and was given the treatment with iapp on (b)(6).On (b)(6) 2018, she was given the seventh treatment with iapp of plasmaflo op-o5w and immusorba tr-350 for myasthenia gravis.Just after catheter withdrawal, this patient experienced respiratory discomfort.Conclusion of air in her blood was suspected to have occurred, and chest x-ray was taken, which showed opacity like the diffuse pneumonia in her left lung.Soon after she returned to the hospital ward, her symptom worsened and oxygen was given via oxygen mask, but still she could not maintain her breathing, and she was given the treatment with ventilator.Acute respiratory distress syndrome(ards) was suspected, and she was given the treatment of antibiotic meropenem and elaspol, but she could not wean from mechanical ventilator.On (b)(6) 2018, this patient was admitted to another hospital, and was given the treatment with antifungal agent for allergic bronchopulmonary mycoses.In the end of march, she was given the conservative medical management.She has recovered and was discharged from the hospital.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PLASMAFLO OP
Type of Device
PLASMA SEPARATOR
Manufacturer (Section D)
ASAHI KASEI MEDICAL CO., LTD.
1-105, kanda jinbocho
chiyoda-ku
tokyo 101-8 101
JA  101-8101
Manufacturer (Section G)
ASAHI KASEI MEDICAL MT CORP.
oita works
2111-2 oaza sato
oita-shi, oita 870-0 396
JA   870-0396
Manufacturer Contact
akitake yamashita
1-105, kanda jinbocho
chiyoda-ku
tokyo 101-8-101
JA   101-8101
32963735
MDR Report Key7497644
MDR Text Key107694678
Report Number8010002-2018-00040
Device Sequence Number1
Product Code MDP
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P820033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Physician
Type of Report Initial
Report Date 04/13/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/09/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberOP-05W
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/13/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
BLOOD PURIFICATION MACHINE ACH-SIGMA; CALFINA TAB.0.5; CLARITHROMYCIN TABLET; HEPARIN; IMMUSORBA TR-350; LANSOPRAZOLE ORALLY-DISINTEGRATING TABLET; PLASMAPHERESIS BLOOD TUBING SET PA-SG; PREDNISOLONE 5MG TABLET; THEOPHYLLINE EXTENDED-RELEASE TABLET 100MG
Patient Outcome(s) Life Threatening;
Patient Age50 YR
Patient Weight30
-
-